BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $218,645 | +1.5% | 5,794 | +22.6% | 0.00% | 0.0% |
Q2 2023 | $215,338 | +2.3% | 4,727 | -8.9% | 0.00% | 0.0% |
Q1 2023 | $210,446 | -39.6% | 5,189 | -24.1% | 0.00% | -50.0% |
Q4 2022 | $348,323 | +15.0% | 6,833 | +21.5% | 0.01% | +14.3% |
Q3 2022 | $303,000 | -18.3% | 5,623 | -2.6% | 0.01% | -22.2% |
Q2 2022 | $371,000 | -35.3% | 5,773 | -21.8% | 0.01% | -25.0% |
Q1 2022 | $573,000 | -13.1% | 7,386 | -3.8% | 0.01% | -7.7% |
Q4 2021 | $659,000 | +23.2% | 7,675 | +15.4% | 0.01% | +8.3% |
Q3 2021 | $535,000 | -2.0% | 6,651 | -1.9% | 0.01% | 0.0% |
Q2 2021 | $546,000 | -16.4% | 6,778 | -12.5% | 0.01% | -25.0% |
Q1 2021 | $653,000 | -12.8% | 7,743 | -17.0% | 0.02% | -20.0% |
Q4 2020 | $749,000 | +19.3% | 9,332 | +19.4% | 0.02% | +5.3% |
Q3 2020 | $628,000 | -7.0% | 7,813 | -0.3% | 0.02% | -13.6% |
Q2 2020 | $675,000 | +9.8% | 7,839 | +3.4% | 0.02% | -4.3% |
Q1 2020 | $615,000 | +1.3% | 7,582 | +4.4% | 0.02% | +15.0% |
Q4 2019 | $607,000 | +53.3% | 7,259 | +60.3% | 0.02% | +33.3% |
Q3 2019 | $396,000 | +11.5% | 4,529 | +4.6% | 0.02% | +7.1% |
Q2 2019 | $355,000 | -1.7% | 4,331 | -2.2% | 0.01% | -6.7% |
Q1 2019 | $361,000 | +21.1% | 4,429 | -2.3% | 0.02% | +7.1% |
Q4 2018 | $298,000 | -20.1% | 4,534 | -6.3% | 0.01% | +7.7% |
Q3 2018 | $373,000 | +0.3% | 4,840 | -3.8% | 0.01% | -7.1% |
Q2 2018 | $372,000 | +14.1% | 5,033 | +0.4% | 0.01% | +16.7% |
Q1 2018 | $326,000 | -49.6% | 5,013 | -49.9% | 0.01% | -40.0% |
Q4 2017 | $647,000 | +113.5% | 10,012 | +107.2% | 0.02% | +53.8% |
Q3 2017 | $303,000 | +13.5% | 4,833 | +9.7% | 0.01% | 0.0% |
Q2 2017 | $267,000 | +14.1% | 4,404 | -2.3% | 0.01% | +8.3% |
Q1 2017 | $234,000 | – | 4,509 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |